Piperacillin and Tazobactam for Injection Recalled Over Illness Hazard
Versions of Piperacillin and Tazobactam for Injection, USP 40.5 grams with expiration dates ranging from this month to April of next year are being recalled by Apotex Corporation and Hospira because of a possible threat to patient health. In 15 lots of this product, the IV line or bag could sustain crystallization or precipitation, a condition that may not only prevent proper delivery of the aforementioned drugs, but that could also lead to a host of complications, such as vasculitis, renal impairment, phlebitis, and more. The drug, which is typically given to patients suffering from certain infections, should not be used. Instead, doctors are being asked to quarantine the products and arrange for the proper return of the drugs with GENCO.
To learn more about the recall, follow this link.